Renovaro Inc. (RENB) Dividend History

Renovaro Inc. (RENB) is a company specializing in innovative solutions for the renovation and construction industries. It focuses on developing and providing advanced materials, tools, and technologies aimed at improving the efficiency, safety, and sustainability of building and renovation projects.

Century City Medical Plaza, Suite 906 Los Angeles, CA, 90067
Phone: 45 39179840
Website: https://www.renovarogroup.com

Dividend History

Renovaro Inc. currently does not pay dividends

Company News

UPDATE - Renovaro Inc. Announces Expedited Trial for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology

Renovaro Inc. has received a ruling to expedite a trial in 2025 for a lawsuit it filed against Predictive Oncology Inc., seeking to enforce a binding merger agreement executed on January 1, 2025. Renovaro alleges that Predictive Oncology breached the agreement's exclusivity and good faith negotiation provisions.

Benzinga

Featured Companies: POAI
Renovaro Inc. Announces Expedited Trail for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology

Renovaro Inc. has filed a lawsuit against Predictive Oncology Inc. to enforce a binding merger agreement, alleging that Predictive Oncology breached the agreement's exclusivity and good faith negotiation provisions.

Benzinga

Featured Companies: POAI
Predictive Oncology Reports Year-End 2024 Financial Results and Provides Corporate Update

Predictive Oncology reported a loss of $10.8 million on $1.6 million in revenue for 2024. The company announced an agreement to merge with Renovaro, Inc. and the receipt of financing to integrate their AI/ML platform and laboratory capabilities.

GlobeNewswire Inc.

Featured Companies: POAI
Renovaro and BioSymetrics Announce Definitive Merger Agreement to Advance AI-Driven Biomarker Discovery and Precision Medicine

Renovaro and BioSymetrics, two companies focused on AI-driven biomarker discovery and precision medicine, have announced a merger agreement to enhance their capabilities in these areas.

Benzinga
Investors Eye Biotech Sector as Cancer Therapy Market Surges

The global cancer therapy market is expected to grow significantly, driven by advancements in cancer detection and treatment technologies. Several biotech companies, including Oncolytics Biotech, GRAIL, Quest Diagnostics, Renovaro, and Predictive Oncology, have made notable progress in their respective cancer-focused initiatives.

Benzinga

Featured Companies: DGX GRAL ONCY POAI

Dividend data last updated 06/07/2025 08:15:23 UTC